Nothing Special   »   [go: up one dir, main page]

IT1254136B - Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica. - Google Patents

Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Info

Publication number
IT1254136B
IT1254136B ITRM920028A ITRM920028A IT1254136B IT 1254136 B IT1254136 B IT 1254136B IT RM920028 A ITRM920028 A IT RM920028A IT RM920028 A ITRM920028 A IT RM920028A IT 1254136 B IT1254136 B IT 1254136B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
acil
contain
long chain
aliphatic alcohols
Prior art date
Application number
ITRM920028A
Other languages
English (en)
Inventor
Mose Santaniello
Maria Ornella Tinti
Domenico Misiti
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM920028A0 publication Critical patent/ITRM920028A0/it
Priority to ITRM920028A priority Critical patent/IT1254136B/it
Priority to ZA93161A priority patent/ZA93161B/xx
Priority to CA002087084A priority patent/CA2087084C/en
Priority to JP00475793A priority patent/JP3294652B2/ja
Priority to DE69309725T priority patent/DE69309725T2/de
Priority to AT93830010T priority patent/ATE151744T1/de
Priority to DK93830010.0T priority patent/DK0552138T3/da
Priority to EP93830010A priority patent/EP0552138B1/en
Priority to ES93830010T priority patent/ES2101998T3/es
Priority to KR1019930000523A priority patent/KR100251887B1/ko
Publication of ITRM920028A1 publication Critical patent/ITRM920028A1/it
Priority to US08/250,108 priority patent/US5519056A/en
Priority to US08/409,714 priority patent/US5525627A/en
Application granted granted Critical
Publication of IT1254136B publication Critical patent/IT1254136B/it
Priority to GR960403681T priority patent/GR3023163T3/el
Priority to HK98104939A priority patent/HK1005864A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Esteri di acil L-carnitine di formula generale (I) (FORMULA I) in cui R è acile lineare o ramificato avente da 2 a 16 atomi di carbonio in particolare isobutirrile e isovalerile;n è un intero compreso fra 10 e 15, particolarmente 10; e X- è l'anione di un acido farmacologicamente accettabile sono dotati di potente azione antimicotica, particolarmente nei confronti di funghi lievitomorfi, come ad esempio la Candida albicans agente eziologico delle candidosi e di funghi filamentosi, come ad esempio l'Aspergillus fumigatus agente eziologico dell'aspergillosi.Composizioni farmaceutiche somministrabili per via orale, parenterale o per uso topico, comprendono un estere di formula (I) quale principio attivo.
ITRM920028A 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica. IT1254136B (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
ITRM920028A IT1254136B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.
ZA93161A ZA93161B (en) 1992-01-16 1993-01-11 Esters of acyl carnitines with long-chain alpihatic alcohols and pharmaceutical compositions containing same having antibacterial activity
CA002087084A CA2087084C (en) 1992-01-16 1993-01-11 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
JP00475793A JP3294652B2 (ja) 1992-01-16 1993-01-14 アシルカルニチンエステル類および抗真菌活性医薬組成物
DK93830010.0T DK0552138T3 (da) 1992-01-16 1993-01-15 Anvendelse af estere af acylcarnitiner med langkædede alifatiske alkoholer til fremstilling af farmaceutiske præparater med antimykotisk aktivitet.
AT93830010T ATE151744T1 (de) 1992-01-16 1993-01-15 Verwendung von estern des acyl-carnitins mit langkettigen aliphatischen alkoholen zur herstellung von pharmazeutischen zusammensetzungen mit antimykotischer wirkung
DE69309725T DE69309725T2 (de) 1992-01-16 1993-01-15 Verwendung von Estern des Acyl-Carnitins mit langkettigen aliphatischen Alkoholen zur Herstellung von pharmazeutischen Zusammensetzungen mit antimykotischer Wirkung
EP93830010A EP0552138B1 (en) 1992-01-16 1993-01-15 Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity
ES93830010T ES2101998T3 (es) 1992-01-16 1993-01-15 Uso de esteres de acilcarnitinas con alcoholes alifaticos de cadena larga para la preparacion de composiciones farmaceuticas con actividad antimicotica.
KR1019930000523A KR100251887B1 (ko) 1992-01-16 1993-01-16 긴 사슬의 지방족 알콜을 가진 아실카르니틴 에스테르와 항진균 활성을 지닌 그의 약제조성물
US08/250,108 US5519056A (en) 1992-01-16 1994-05-26 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
US08/409,714 US5525627A (en) 1992-01-16 1995-03-24 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity
GR960403681T GR3023163T3 (en) 1992-01-16 1997-04-17 Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity
HK98104939A HK1005864A1 (en) 1992-01-16 1998-06-05 Use of esters of acyl carnitines with long-chain aliphatic alcohols in the preparation of pharmaceutical compositions having antimycotic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920028A IT1254136B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Publications (3)

Publication Number Publication Date
ITRM920028A0 ITRM920028A0 (it) 1992-01-16
ITRM920028A1 ITRM920028A1 (it) 1993-07-16
IT1254136B true IT1254136B (it) 1995-09-08

Family

ID=11400574

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920028A IT1254136B (it) 1992-01-16 1992-01-16 Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Country Status (13)

Country Link
US (2) US5519056A (it)
EP (1) EP0552138B1 (it)
JP (1) JP3294652B2 (it)
KR (1) KR100251887B1 (it)
AT (1) ATE151744T1 (it)
CA (1) CA2087084C (it)
DE (1) DE69309725T2 (it)
DK (1) DK0552138T3 (it)
ES (1) ES2101998T3 (it)
GR (1) GR3023163T3 (it)
HK (1) HK1005864A1 (it)
IT (1) IT1254136B (it)
ZA (1) ZA93161B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258370B (it) * 1992-03-02 1996-02-26 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.
IT1261828B (it) * 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US5741816A (en) * 1994-06-20 1998-04-21 Tanabe Seiyaku Co., Ltd. Hair-growth agent
IT1277898B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso di amminoacidi basici, di acil derivati di amminoacidi basici e di loro sali farmaceuticamente accettabili per la profilassi di malattie
IT1283955B1 (it) * 1996-03-20 1998-05-07 Sigma Tau Ind Farmaceuti Bis alcanoil esteri della carnitina ad attivita' antibatterica, antimicotica ed antiprotozoaria.
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588443A5 (it) * 1974-09-25 1977-06-15 Lonza Ag
CH596147A5 (it) * 1974-09-25 1978-02-28 Lonza Ag
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1170861B (it) * 1981-03-31 1987-06-03 Sigma Tau Ind Farmaceuti Ester di mercaptoacil-carnitine procedimento per la loro preparazione e loro uso terapeutico
IT1191945B (it) * 1986-06-04 1988-03-31 Avantgarde Spa N-alchilammidi della d(+)-carnitina dotate di attivita' antibatterica,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1235494B (it) * 1987-12-02 1992-09-04 Avantgarde Spa N-alchilammidi della dl e l(-)carnitina dotate di attivita' antibatterica, procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
IT1231751B (it) * 1989-04-12 1991-12-21 Sigma Tau Ind Farmaceuti Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
IT1240775B (it) * 1990-02-23 1993-12-17 Sigma Tau Ind Farmaceuti Esteri della l-carnitina e di acil-l-carnitine con l'acido beta-idrossibutirrico e composizioni farmaceutiche che li contengono per la inibizione della degenerazione neuronale, della proteolisi epatica e nel trattamento del coma.

Also Published As

Publication number Publication date
KR100251887B1 (ko) 2000-05-01
DE69309725D1 (de) 1997-05-22
US5525627A (en) 1996-06-11
CA2087084A1 (en) 1993-07-17
DK0552138T3 (da) 1997-10-20
ITRM920028A0 (it) 1992-01-16
HK1005864A1 (en) 1999-01-29
CA2087084C (en) 2003-12-23
GR3023163T3 (en) 1997-07-30
JP3294652B2 (ja) 2002-06-24
EP0552138A2 (en) 1993-07-21
KR930016392A (ko) 1993-08-26
ES2101998T3 (es) 1997-07-16
EP0552138B1 (en) 1997-04-16
ATE151744T1 (de) 1997-05-15
US5519056A (en) 1996-05-21
DE69309725T2 (de) 1997-07-31
ITRM920028A1 (it) 1993-07-16
EP0552138A3 (en) 1993-10-20
ZA93161B (en) 1993-10-06
JPH05339219A (ja) 1993-12-21

Similar Documents

Publication Publication Date Title
US4912124A (en) Antifungal dermatological solution
US6486106B1 (en) Composition
JP2688473B2 (ja) レチノールを主成分とする化粧または薬理組成物
KR960030936A (ko) 활성 성분으로 god형 엘라지타닌을 함유하는 히알루로니다제 억제제
ZA200501715B (en) Solution for ungual application
KR960703339A (ko) 비강 투여를 위한 데스모프레신 조성물
CA2215327A1 (en) Formulations for lipophilic compounds
IT1254136B (it) Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.
KR950000142A (ko) 피부질환치료용 약제조성물 제조에 사용되는 히드록시산함유 l-카르니틴에스테르 및 아실 l-카르니틴에스테르의 용도
JP2022173381A (ja) 外用組成物
IT1254135B (it) Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica.
IT1248321B (it) Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
ES2628707T3 (es) Composición tópica potenciada
JP2022177246A (ja) 外用組成物
MD1471G2 (ro) Remediu medicamentos antibacterian şi antimicotic
IE802606L (en) Pharmaceutical composition
MD1471F1 (en) Antibacterial and antifungal medicinal agent
CA2303132C (en) Intranasal formulations containing scopolamine and method of treating motion sickness
KR970706828A (ko) 경피 투여형 제제(percutaneously administrable preparation)
SU1796185A1 (ru) Фунгицид 2
ATE350007T1 (de) Treibgasfreie sprayzubereitungen
GB1209560A (en) Antidandruff compositions
MD1779G2 (ro) Compoziţie dermatologică peliculogenă cu juglonă (variante)
JP2001039922A (ja) ソルビン酸類の分解抑制方法及び液剤組成物
JPH09169642A (ja) テトラヒドロゾリン含有液剤